Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Maman Ibrahim - Why Pharma Risk Registers Misclassify Their Biggest Third-Party Exposures
Why Pharma Risk Registers Misclassify Their Biggest Third-Party Exposures
Forbes

Maman Ibrahim is a cyber and digital risk executive, helping boards, CRO, CIO, and CISO turn risk work into decisions, delivery, and proof. In my work advising pharmaceutical leadership teams on risk governance, I see the same pattern recur with…

washingtonexaminer.com - David Marin - It's time for Congress to end Big Pharma's war on generics
It's time for Congress to end Big Pharma's war on generics
Washington Examiner

The concept here is pretty simple. When there is generic drug competition, brand drugmakers have to compete on price. Employers, government programs, and the pharmacy benefit managers they hire are able to secure better deals or simply include…

theamericanreporter.com - Sargundeep Kaur - How BioMarin Pharma is Planning to Grow Their Revenue?
How BioMarin Pharma is Planning to Grow Their Revenue?
The American Reporter

Not every pharmaceutical company grows by discovering the next breakthrough drug. Some create more value from the medicines they already have. BioMarin Pharmaceutical is following that path, focusing on expanding existing blockbuster products…

thehindu.com - The Hindu Bureau - Aurobindo Pharma's generic of rheumatoid arthritis drug secures U.S. FDA nod
Aurobindo Pharma's generic of rheumatoid arthritis drug secures U.S. FDA nod
The Hindu

Generic drugmnaker Aurobindo Pharma has received U.S. Food and Drug Administration (U.S. FDA) final approval to manufacture and market Tofacitinib tablets, 5 mg and 10 mg. The product is bioequivalent and therapeutically equivalent to reference…

thehindubusinessline.com - Buzzing stocks, June 5: Ola Electric, Maruti, Inox Clean, CG Power, TVS Supply Chain, Aurobindo Pharma
Buzzing stocks, June 5: Ola Electric, Maruti, Inox Clean, CG Power, TVS Supply Chain, Aurobindo Pharma
BusinessLine

Ola Electric Mobility has raised Rs 780 crore through a qualified institutional placement (QIP) that was oversubscribed 56 per cent, driven by strong participation from domestic and global institutional investors, stock exchange data showed on…

marketwatch.com - U.S. Futures, European Stocks Mixed as Cooling AI Trade, Fragile Ceasefire Weigh
U.S. Futures, European Stocks Mixed as Cooling AI Trade, Fragile Ceasefire Weigh
MarketWatch

U.S. futures for the S&P 500 were down 0.7% and futures for the Dow Jones Industrial Average were flat. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the Stoxx Europe 600 dropped 0.2% in morning trading.

statnews.com - Ed Silverman - Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
STAT

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where the official mascots are snoozing in their respective corners. This means we are free to focus on the matters at hand…

forbes.com - Amy Feldman - Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Forbes

Chai Discovery cofounders Josh Meier (left) and Jack Dent ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk.

thestandard.com.hk - The Standard 英文虎報 - Mixed gray market turnout for 3 new listings ahead of debuts
Mixed gray market turnout for 3 new listings ahead of debuts
The Standard

Three new listings delivered mixed performances in Hong Kong's gray market on Thursday, just a day ahead of their debuts. SCROLL TO CONTINUE WITH CONTENT LongBio Pharma (Suzhou) surged among three major gray markets, rising about 56 percent from…

swissinfo.ch - swissinfo.ch - Roche chair compares US tariff policy to 'blackmail
Roche chair compares US tariff policy to 'blackmail
www.swissinfo.ch

“Our main concern at the moment is the rise of protectionism in our most important markets, the United States and China”, said Schwan at the Swiss Economic Forum (SEF) in Interlaken. The US and China are using their dominant market…

foxnews.com - Robert Schmad - Platner's anti-corporate crusade hits awkward snag as receipts tell another story
Platner's anti-corporate crusade hits awkward snag as receipts tell another story
Fox News

Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has…

bloomberg.com - Jef Feeley - Merck to Settle Bulk of Gardasil Suits for About $50 Million
Merck to Settle Bulk of Gardasil Suits for About $50 Million
Bloomberg

Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker's blockbuster Gardasil cancer vaccine for causing autoimmune ailments that affect young women's hearts and reproductive systems for an amount that is “not…

marketwatch.com - Photocure ASA Acquires Vesica Health in $30.5 Million Deal
Photocure ASA Acquires Vesica Health in $30.5 Million Deal
MarketWatch

Photocure ASA has acquired the precision diagnostics company Vesica Health in a $30.5 million cash-and-stock deal. The Norwegian specialty pharma company said Thursday that it wanted to snag the U.S.-based Vesica's flagship urine-based molecular…

bloomberg.com - Fabienne Kinzelmann - Roche Chairman Accuses US Government of Drug Price 'Blackmail'
Roche Chairman Accuses US Government of Drug Price 'Blackmail'
Bloomberg

Roche Holding AG Chairman Severin Schwan accused the US government of using heavy-handed tactics over drug prices and warned it could have a negative long-term impact on Europe. The Swiss drug company agreed a pact with President Donald Trump's…

snaplogic.com - Dominic Wellington - What It Takes To Get a Giant Pharmaceutical Company's Data Infrastructure Ready for AI
What It Takes To Get a Giant Pharmaceutical Company's Data Infrastructure Ready for AI
SnapLogic

The SnapLogic team has been on the road again, this time in London, to catch up on the current state of AI in the pharmaceutical industry and explore its future direction. As the name implies, Digi-Tech Pharma & AI is an event focused on the…

Receive a Daily briefing on Pharma Industry News

Get Started